Expert Report: Navigating the Corporate Gross Income Test ($\$100$ Million QSB) for the Connecticut R&D Tax Credit

The Corporate Gross Income Test defines a Qualified Small Business (QSB) for Connecticut R&D tax credit purposes as a corporation whose gross income for the previous income year does not exceed $\mathbf{\$100}$ million. Achieving QSB status is critical because it grants access to a significantly superior, fixed $\mathbf{6\%}$ Non-Incremental R&D Credit rate on all qualified Connecticut R&D expenditures (RDC Credit, CGS § 12-217n), bypassing the lower, tiered rates applied to larger corporations.

I. Introduction to the Connecticut R&D Tax Credit Landscape

A. Dual R&D Credit Structures in Connecticut

Connecticut employs a sophisticated, dual-track approach to incentivize research and development activities conducted within the state, primarily through two distinct credits applicable against the Corporation Business Tax (Chapter 208 of the Connecticut General Statutes).1 Understanding both mechanisms is essential for maximizing tax benefits.

The first mechanism is the Research and Experimental Expenditures Tax Credit (RC Credit), often referred to as the Incremental method (CGS § 12-217j). This credit is equal to 20% of the incremental increase in qualified research and experimental expenses (QREs) during the current income year that exceed the amount incurred in the preceding income year.3 This structure is primarily designed to reward companies that demonstrate significant year-over-year growth in their R&D spending. The second mechanism is the Research and Development Expenses Tax Credit (RDC Credit), or the Non-Incremental method (CGS § 12-217n).3 The RDC credit applies a percentage rate, which is either a fixed flat rate or a tiered, graduated scale, to the total qualified R&D expenses incurred in the current year, irrespective of prior year spending.4

It is important to note that taxpayers are permitted to elect both the Incremental (RC) and the Non-Incremental (RDC) methods in a single tax year.6 This flexibility allows corporate tax departments to model their potential benefit under both regimes, ensuring the maximum available credit is calculated and claimed, subject to the overall limitation on credit utilization. For income years beginning on or after January 1, 2023, the amount of R&D tax credits claimed is capped at 70% of the corporate business tax liability, following a phase-in from 50.01%.3

B. The Strategic Importance of the Non-Incremental Credit (RDC)

The RDC Credit (CGS § 12-217n) holds particular strategic importance because it offers a stable, predictable tax benefit tied directly to current-year spending, mitigating the volatility associated with year-to-year R&D fluctuations inherent in the Incremental (RC) method.5 For mid-sized companies and startups, achieving the Qualified Small Business (QSB) status under the RDC regime provides access to the most generous fixed credit rate available.

Companies engaged in multi-year planning must model both the Incremental (RC) and Non-Incremental (RDC) methods annually to determine the optimal claim. The 6% flat rate available through the RDC QSB status is typically most advantageous for companies whose R&D expenditures are stable, slowly growing, or even slightly declining, where the high threshold of the 20% incremental credit is difficult to meet.4 Conversely, a company experiencing steep, rapid growth in R&D spending may see greater benefits from the 20% incremental credit, provided the QRE base year is sufficiently low. The inherent predictability of the RDC credit, particularly the QSB flat rate, makes its qualifying threshold—the $\$100$ million gross income test—a primary focus for tax planning.

II. The Corporate Gross Income Test: Definition of a Qualified Small Business (QSB)

The QSB definition is foundational to maximizing benefits under CGS § 12-217n, granting access to the premium 6% credit rate.

A. Statutory Foundation of the $\mathbf{\$100}$ Million Threshold

The definition of a Qualified Small Business (QSB) is explicitly codified in CGS § 12-217n(b)(4), establishing two simultaneous criteria that must be met.8

The first criterion is the Gross Income Threshold: QSB status is available to a company that “has gross income for the previous income year that does not exceed one hundred million dollars”.8 The reliance on the previous income year‘s gross income, rather than the current year’s projected income, provides R&D cost managers and tax professionals with immediate, reliable certainty regarding the applicable credit rate before the current year’s R&D expenses are even incurred.9 This minimizes risk and facilitates accurate budgeting and financial provisioning.

The second criterion is the Anti-Abuse Provision: The company must also certify that it “has not, in the determination of the commissioner, met the gross income test through transactions with a related person, as defined in section 12-217w”.8 This provision acknowledges the potential for corporate restructuring or intercompany transactions to artificially deflate gross income to qualify for the favorable small business rate. This mandatory review of related-party dealings is a critical compliance checkpoint.

B. Defining “Gross Income” and Reference to Federal Tax Forms

Connecticut statute relies on the figure for “gross income” for the determination of QSB status, derived from the corporation’s financials of the preceding income year.9 While CGS § 12-217n does not provide a separate, state-specific calculation methodology for this figure, guidance from the Connecticut Department of Revenue Services (DRS) regarding the Corporation Business Tax return (Form CT-1120) directs taxpayers to use the amount reported on Line 11 of the federal Form 1120, U.S. Corporation Income Tax Return.11

For federal C-corporation reporting, Line 11 of Form 1120 generally represents gross income derived from sales, services, interest, dividends, royalties, and other gross receipts, less the cost of goods sold. This established reliance on the federal definition promotes consistency in reporting and avoids the necessity of a separate, complex state-level gross income calculation solely for the QSB test. Tax professionals must ensure that any adjustments or modifications made to the federal income calculation are considered in the context of the state’s reference point.

C. The Financial Advantage: QSB 6% Flat Rate

The primary financial incentive driving the pursuit of QSB status is the substantial elevation of the non-incremental credit calculation rate.

A Qualified Small Business automatically calculates its tentative credit at a flat rate of 6% of its total in-state R&D expenses (QREs).4 This flat rate structure is highly favorable because it applies the maximum 6% rate from the first dollar of qualified spending, eliminating the initial low-rate tiers that larger companies must utilize.

Companies exceeding the $\$100$ million gross income threshold (Non-QSBs) are subject to a graduated, tiered rate structure. These rates range from a low of 1% for the first $\$50$ million in expenditures up to a maximum of 6% only for expenditures exceeding $\$200$ million.4 The advantage of QSB status is starkest for entities with moderate R&D budgets. For a non-QSB, only when total R&D expenses exceed $\$200$ million does the marginal rate reach 6%, meaning the average effective credit rate for a Non-QSB will be significantly lower than 6% unless expenditures are massive. This structured difference delivers the greatest financial advantage precisely for those companies with QREs below $\$200$ million, ensuring they receive the full 6% benefit without navigating the lower tiers.

The tiered structure for Non-QSB entities is detailed below 4:

III. Statutory Interpretation: Related Person Aggregation Rules

The second requirement for QSB status involves a mandate for reviewing transactions with related persons, preventing structural manipulation to qualify for the $\$100$ million threshold.9

A. Definition of a “Related Person” (CGS § 12-217w)

The Connecticut General Statutes (CGS) defines a “related person” by cross-reference to CGS § 12-217w, which governs fixed capital investment credits.1 For the purposes of claiming the R&D credit, a “related person” refers to “a corporation, partnership, association or trust controlled by such corporation” (the corporation claiming the credit).14

This definition centers on the concept of control. While the statute does not explicitly define the necessary level of control (e.g., majority ownership or voting power), the context typically implies a review of beneficial ownership structures or effective managerial control within the affiliated group. This structured definition ensures that the test applies to the entire economic enterprise under common oversight, not just the isolated legal entity claiming the credit.

B. Application of the Anti-Abuse Test and Economic Aggregation

The anti-abuse provision found in CGS § 12-217n(b)(4)(B) grants explicit authority to the Commissioner of Economic and Community Development (DECD) to review whether the taxpayer met the gross income test through transactions with a related person.8 This delegation of authority to the Commissioner is a significant aspect of the law, suggesting that the Commissioner may challenge QSB status if evidence points to artificial reduction of gross income through intercompany asset or revenue shifting.

The statutory requirement necessitates an implied economic aggregation mandate. Taxpayers cannot satisfy the $\$100$ million QSB threshold merely by examining the gross income of the single legal entity claiming the credit if that entity is part of an affiliated group. The claiming entity must analyze the aggregate gross income of all entities controlled by it or under common control, confirming that the total combined gross income does not exceed the threshold. This aggregation is a defensive measure required to demonstrate to the state that the QSB status reflects the true economic scale of the corporate enterprise, rather than a tax avoidance strategy.1 For large, multi-entity corporate structures, meticulous documentation of related-party transactions and the aggregate gross income calculation is essential for compliance.

C. Interaction with Combined Unitary Filing

Connecticut mandates combined unitary tax reporting under CGS § 12-222 for certain affiliated groups.8 The application of the QSB test must be considered in this context.

The statute governing R&D expenses (CGS § 12-217n) specifies that research expenses are still deemed qualified even if they are funded by another person, provided that person is included in a combined return with the entity incurring the expenses.8 This rule simplifies the treatment of intercompany R&D funding within a unitary group. However, the $\$100$ million QSB gross income test must still be evaluated based on the economic reality of the unitary group. If the group is mandated to file a combined return, the threshold analysis is typically performed using the total, aggregate gross income reported on the combined return for the preceding income year. The Commissioner’s authority to scrutinize related-party manipulation remains paramount, ensuring that QSB eligibility is assessed at the scale of the entire consolidated enterprise.

IV. Department of Revenue Services (DRS) Guidance and Compliance

The Connecticut Department of Revenue Services (DRS) provides administrative guidance through its publications and forms, clarifying the application and compliance requirements for the R&D tax credits.

A. Review of Statutory Qualified Expenses (QREs)

DRS guidance confirms that the expenses eligible for the RDC credit must meet specific federal criteria, coupled with a strict geographic limitation to Connecticut.1

Federal Conformity (Historical): Connecticut defines “Research and development expenses” by reference to the Internal Revenue Code (IRC).9 Specifically, QREs include research or experimental expenditures deductible under IRC § 174 of 1986, as in effect on May 28, 1993, along with basic research payments as defined under IRC § 41.8 The use of the specific 1993 federal date means Connecticut successfully decoupled its R&D credit from the adverse federal mandate, introduced in 2022, requiring the capitalization and amortization of R&D expenses over five or fifteen years. This decoupling is advantageous, as it preserves the value and immediacy of the QRE calculation for state credit purposes, even when the federal deduction is delayed.

Geographic and Scope Limitations:

1. The expenditures and payments must be paid or incurred for research and experimentation and basic research conducted in Connecticut.1
2. Specific expenditures that do not qualify include overhead and general administrative expenses not directly related to the research effort, ordinary quality control testing, consumer surveys, management studies, advertising, promotions, or acquiring another business’s patent or process.1

B. Compliance Forms and Administrative Procedures

To claim the Non-Incremental R&D Credit (RDC), QSBs must utilize specific forms issued by the DRS. The primary document is Form CT-1120 RDC, which is used to calculate the tentative tax credit, including the 6% rate for QSBs.10 This form requires the taxpayer to document their total Connecticut R&D expenses and apply the appropriate rate based on their QSB status.

The claimed credit is then applied against the Corporation Business Tax liability. For income years beginning in 2023 and subsequent years, the total amount of R&D credits (combined Incremental and Non-Incremental) claimed is restricted to 70% of the corporation’s annual tax liability.3 This limitation ensures that corporations retain a base level of tax obligation in Connecticut. Any unused credits earned in income year 2021 and thereafter may be carried forward for up to 15 income years, while credits earned in prior years enjoy an unlimited carryforward period.3

V. Critical Nuance: The Refundability Test ($\$70$ Million Threshold)

A critical distinction for corporate tax planning involves two separate gross income thresholds within the Connecticut R&D tax credit regime. The $\$100$ million test grants access to the high 6% rate, but a separate, lower threshold determines access to cash refundability.3

A. Eligibility Requirements for Credit Exchange (Refundability)

Connecticut allows a mechanism for Qualified Small Businesses to exchange their unused R&D credits for a cash refund, providing immediate liquidity to companies that have invested in R&D but lack sufficient tax liability to utilize the credit.17 This process is governed by CGS § 12-217ee.

1. Strict Gross Income Threshold for Exchange: The taxpayer’s gross income for the previous income year must not exceed $\mathbf{\$70}$ million.3 This is substantially lower than the $\$100$ million threshold required merely to calculate the credit at the 6% rate. This demonstrates a clear policy objective: the 6% rate targets broader mid-market competitiveness, whereas the exchange option targets liquidity for smaller, capital-constrained startups and early-stage growth companies.
2. No Tax Liability Requirement: Eligibility for the exchange also requires that the company be fundamentally unable to use the credit due to its financial position.17 This condition is met if:

• The company’s apportioned net income is zero or negative, regardless of the amount of its capital base tax liability; or
• The company’s capital base tax is equal to the minimum tax of $\$250$.17

3. The Refund Rate and Cap: If a QSB meets both the $\$70$ million gross income test and the no tax liability requirement, it may exchange its unused RC or RDC credits for a cash refund equal to 65% of the credit’s value.3 This exchange is subject to an annual limit of $1,500,000 for any one income year.4
4. Exchange Procedure: The application for refund is performed using Form CT-1120 XCH (Application for Exchange of Research and Development or Research and Experimental Expenditures Tax Credits by a Qualified Small Business), which must be filed separately from the primary tax return (Form CT-1120 or CT-1120CU).11 Only credits earned and eligible to be claimed in the current year may be exchanged.16

B. Strategic Implications of the Dual Threshold

The imposition of these two distinct thresholds establishes two categories of QSBs, each with different tax planning options related to credit monetization.

Companies with gross income between $\$70$ million and $\$100$ million benefit significantly from the 6% R&D rate but are ineligible for the liquidity offered by the exchange program. For these entities, the unused credits must be managed through the 15-year carryforward period. Conversely, entities below the $\$70$ million threshold have the ultimate flexibility, possessing both the favorable rate structure and the option to monetize excess credits immediately, which is crucial for funding ongoing operations and R&D investment.

VI. Case Study: Application of the QSB Gross Income Test and Dual Thresholds

This example illustrates the practical application and interaction of the $\mathbf{\$100}$ million QSB test and the $\mathbf{\$70}$ million refundability test.

Scenario: High-Growth Technology Solutions Inc. (HGTS)

HGTS is a standalone Connecticut-based manufacturing company.

Step 1: Determine QSB Status for the 6% Rate (The $\mathbf{\$100M}$ Test)

1. Gross Income Review: HGTS’s 2023 Gross Income is $\$95,000,000$.
2. QSB Qualification: Since $\$95,000,000$ is less than the $\$100,000,000$ threshold, HGTS meets the statutory definition of a QSB under CGS § 12-217n.9
3. Tentative RDC Credit Calculation (QSB Rate): As a QSB, HGTS calculates its tentative credit at the flat 6% rate on all qualified expenses.

• Tentative Credit = $\$5,000,000 \times 6\% = \mathbf{\$300,000}$.

• Comparison Point: If HGTS’s gross income had exceeded $\$100$ million (e.g., $\$105M$), it would be a Non-QSB. Its tentative credit would be calculated using the tiered structure. Since its QREs ($5M) are in the lowest tier ($\le \$50M$), the rate would be only 1%. The resulting tentative credit would be $\$5,000,000 \times 1\% = \mathbf{\$50,000}$. Achieving QSB status resulted in a 500% higher tentative credit value.

Step 2: Determine Credit Utilization and Carryforward

1. Credit Utilization Cap: The credit claimed is capped at 70% of the Corporate Business Tax Liability (for 2024).

• Tax Liability Cap = $\$400,000 \times 70\% = \$280,000$.

1. Credit Claimed: HGTS claims $\$280,000$ of its $\$300,000$ tentative credit.
2. Unused Credit: $\$300,000 – \$280,000 = \mathbf{\$20,000}$ remains unused.

Step 3: Determine Refundability Eligibility (The $\mathbf{\$70M}$ Test)

1. Gross Income Test for Exchange: HGTS’s 2023 Gross Income ($95,000,000) must be compared to the strict exchange threshold of $\mathbf{\$70,000,000}$.18
2. Result: Since $\$95,000,000$ exceeds $\$70,000,000$, HGTS fails the size requirement for the credit exchange program.
3. Conclusion on Monetization: HGTS cannot exchange the unused $\$20,000$ credit for a 65% cash refund. The full unused credit must be carried forward for up to 15 income years.7

VII. Conclusions and Strategic Recommendations

The Connecticut R&D tax credit framework is highly sensitive to corporate gross income, offering the most substantial benefits through the Qualified Small Business (QSB) status under CGS § 12-217n. Successful tax planning requires rigorous adherence to statutory definitions and an understanding of the relationship between the two distinct income thresholds.

A. Key Compliance Directives

1. Affiliated Group Aggregation is Mandatory: Tax professionals must not rely solely on the gross income of the single legal entity incurring the R&D expense. The statutory anti-abuse provision mandates that controlled entities, as defined in CGS § 12-217w, must be reviewed in aggregate for the $\$100$ million test. Failure to perform this analysis exposes the taxpayer to challenge from the Commissioner, as the statute grants explicit authority to scrutinize related-party transactions used to manipulate QSB eligibility.
2. Separate Definition of Gross Income for Exchange: The $\$100$ million threshold for the 6% rate must be maintained as conceptually distinct from the $\$70$ million threshold required for credit refundability. Entities with revenues between $\$70$ million and $\$100$ million, while benefiting from the optimal 6% credit rate, must plan for long-term credit carryforward, as they are not eligible for immediate cash monetization.
3. Rigorous QRE Documentation: The definition of qualified R&D expenses remains tethered to the 1993 version of IRC § 174, a valuable decoupling provision. Companies must ensure their R&D documentation consistently demonstrates that all claimed expenses are paid or incurred for research conducted exclusively within Connecticut and exclude specifically prohibited expenses (e.g., quality control or management surveys).2

B. Strategic Recommendations for Maximizing the Benefit

1. Threshold Management and Modeling: For businesses approaching the $\$100$ million gross income mark, rigorous financial modeling is required. Exceeding this figure results in a drastic reduction in the effective credit rate due to the implementation of the tiered calculation, particularly for companies with R&D expenses under $\$200$ million. Strategic decisions regarding revenue recognition timing in the prior year may be justified to preserve QSB status.
2. Monetization for Early-Stage Companies (Sub- $\mathbf{\$70M}$): Qualified Small Businesses with gross income under $\$70$ million that anticipate insufficient taxable income should prioritize the timely filing of Form CT-1120 XCH. Monetizing unused credits at 65% of face value provides crucial non-dilutive capital and significantly boosts immediate R&D cash flow, supporting ongoing innovation efforts.4
3. Carryforward Strategy: The 15-year carryforward period for post-2020 credits offers flexibility for larger QSBs that cannot access the exchange program. Corporate tax departments must establish robust tracking systems to manage these assets, especially distinguishing them from the unlimited carryforward granted to pre-2021 R&D credits.7

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/